百克生物预计2025年净利亏损2.2亿元至2.8亿元

Core Viewpoint - Baike Biotechnology (688276) is expected to report a net profit loss of between -220 million to -280 million yuan for the fiscal year 2025, indicating a significant decline of 194.79% to 220.64% compared to the previous year [1] Group 1: Company Performance - The company anticipates a net profit loss for 2025, with projections indicating a loss of -2.2 billion to -2.8 billion yuan [1] - This expected loss represents a substantial decrease in profitability compared to the previous year's legally disclosed data [1] Group 2: Industry Challenges - The company cites multiple factors contributing to its challenging operating environment, including intensified industry competition, insufficient public willingness to receive vaccinations, and a decline in the birth rate [1]